Post-infection gut dysbiosis drives systemic inflammation, leaky gut, and immune dysregulation all of which amplify fatigue, cognitive impairment, and mood instability.3 BPC-157 has been shown in multiple animal studies to: Accelerate healing of the intestinal epithelium4 Reduce gut inflammation and restore tight junction integrity5 Modulate the vagus nerve, which connects gut function to brain and immune signaling6 For long COVID patients dealing with GI symptoms, food intolerances, or fatigue that tracks with gut dysfunction, this mechanism is directly relevant
Many patients or their family members are capable of giving IM injections after appropriate training
Am J Physiol Gastrointest Liver Physiol 2006
Once in liquid form, they generally remain stable for up to 30 days when stored properly
What the Research Gap Means in Practice Honesty demands acknowledging the obvious: the human clinical data on stacking BPC-157 with GLP-1 agonists is essentially nonexistent
First, stopping the inflammatory cascade that expands damage from the ischemic core into the penumbra
